Background and activities
Stein Kaasa is Professor of Palliative Medicine at the Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (NTNU). His responsibilities include the development of the core curriculum in palliative medicine and the development of the Nordic specialist postgraduate training curriculum in palliative medicine. Professor Kaasa’s main research interests are: basic research in assessment and classification of symptoms and subjective health; experimental and descriptive clinical studies in palliative medicine and cancer research; pain treatment including translational research on opioids and on cachexia.
Recently, the European Palliaitve Care Research Centre (PRC) was established in Trondheim, Norway; Stein Kaasa is the chair of this research intitative aiming at improving palliative patient care, including end of life care, through research of highest quality in an international setting. He is also chair of the European Association for Palliative Care Research Network (EAPC RN) and the International Association for the Study of Pain (IASP) task force on cancer pain, and principal investigator of the European Palliative Care Research Collaborative (EPCRC). Stein Kaasa is National Cancer Director at the Norwegian Directorate for Health.
Professor Kaasa has published more than 300 articles and book chapters. He has authored the Nordic Textbook of Palliative Care and is co-author of the Oxford Textbook of Palliative Medicine. Professor Kaasa advises many international journals – either as an advisory board member or as a reviewer (Journal of Pain and Symptom Management, Palliative Medicine, Journal of Palliative Medicine, Oncology, Journal of Clinical Oncology, Pain, Lancet Oncology).
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying With cancer in 7 developed countries. Journal of the American Medical Association (JAMA). vol. 315 (3).
- (2016) The Edmonton Symptom Assessment System: Poor performance as a screener for major depression in patients With incurable cancer. Palliative Medicine : A Multiprofessional Journal. vol. 30 (6).
- (2016) Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study. Supportive Care in Cancer. vol. 24 (9).
- (2016) Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Supportive & Palliative Care. vol. 6 (3).
- (2016) Depressive symptoms in the last days of life of patients with cancer: A nationwide retrospective mortality study. BMJ Supportive & Palliative Care. vol. 6 (2).
- (2016) Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical reviews in oncology/hematology. vol. 99.
- (2016) From "breakthrough" to "episodic" cancer pain? A European association for palliative care research network expert Delphi survey toward a common terminology and classification of transient cancer pain exacerbations. Journal of Pain Symptom and Management. vol. 51 (6).
- (2016) Development of an item bank for computerized adaptive test (CAT) measurement of pain. Quality of Life Research. vol. 25 (1).
- (2016) Eir, a computerized tool for symptom management and decision support in cancer care. European Journal of Palliative Care.
- (2016) The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses. Acta Anaesthesiologica Scandinavica. vol. 60 (8).
- (2016) Radiation therapy did not induce long-term changes in rectal mucosa: Results from the randomized scandinavian prostate cancer group 7 trial. International Journal of Radiation Oncology, Biology, Physics. vol. 95 (4).
- (2016) Barriers to and facilitators for implementing quality improvements in palliative care – results from a qualitative interview study in Norway. BMC Palliative Care. vol. 15:61.
- (2016) The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology. vol. 27 (2).
- (2016) Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart?. Supportive Care in Cancer. vol. 24 (6).
- (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica. vol. 54 (3).
- (2015) Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl. PLoS ONE. vol. 10:0137179 (9).
- (2015) Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?. BMJ Open. vol. 5 (5).
- (2015) Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology. vol. 33.
- (2015) Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology. vol. 10 (9).
- (2015) Indicators of integration of oncology and palliative care programs: An international consensus. Annals of Oncology. vol. 26 (9).